Table 1.
Baseline Characteristics
| Patients With Favorable Response (n=39) | Patients With Less Favorable Response (n=45) | P Value | |
|---|---|---|---|
| Follow‐up duration, mo | 6.4 (6.1–12.4) | 6.3 (5.9–12.0) | 0.169 |
| Age, y | 58.2±10.9 | 59.3±8.8 | 0.320 |
| Male, n (%) | 32 (82.1) | 33 (73.3) | 0.341 |
| Clinical presentation, n (%) | 0.049 | ||
| ST‐segment–elevation myocardial infarction, n (%) | 7 (17.9) | 2 (4.4) | |
| Non‐ST‐segment–elevation acute coronary syndrome, n (%) | 21 (53.8) | 21 (46.7) | |
| Stable angina, n (%) | 11 (28.2) | 22 (48.9) | |
| Hypertension, n (%) | 26 (66.7) | 27 (60.0) | 0.528 |
| Dyslipidemia, n (%) | 35 (89.7) | 33 (73.3) | 0.056 |
| Diabetes mellitus, n (%) | 13 (33.3) | 16 (35.6) | 0.831 |
| Chronic kidney disease, n (%) | 2 (5.1) | 5 (11.1) | 0.280 |
| Smoking status, n (%) | 0.476 | ||
| Current smoker | 12 (30.8) | 14 (31.1) | |
| Former smoker | 12 (30.8) | 9 (20.0) | |
| Never smoker | 15 (38.5) | 22 (44.9) | |
| Family history of coronary artery disease, n (%) | 2 (5.1) | 2 (4.4) | 0.636 |
| Discharge medication | |||
| Dual antiplatelet therapy, n (%) | 39 (100.0) | 44 (97.8) | 0.536 |
| Statin, n (%) | 39 (100.0) | 45 (100.0) | 1.000 |
| Intensity of statin therapy | 0.771 | ||
| High‐intensity, n (%) | 1 (2.6) | 1 (2.2) | |
| Moderate‐intensity, n (%) | 34 (87.2) | 37 (82.2) | |
| Low‐intensity, n (%) | 4 (10.2) | 7 (15.6) | |
| Statin naïve, n (%) | 16 (41.0) | 17 (37.8) | 0.761 |
Values are mean±SD, n (%), or median (interquartile range). Significance was calculated by independent‐sample t tests, or by Mann‐Whitney U tests, as appropriate, depending on the normality of the distribution. Sample size: 84 patients.